Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gore

Showing results (21-30 of 314) with videos related to

Pageof 32
Sort By:
Cancer Surveys|January 1, 1989
Lymphomas: the impact of chemotherapy on survivalM E Gore, T J McElwain
Anti-Cancer Drugs|October 1, 1995
The importance of dose and schedule in cancer chemotherapy: epithelial ovarian cancerP N Mainwaring, M E Gore
Drugs|July 24, 2001
Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapyD D Gibbs, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Impact of doxorubicin on survival in advanced ovarian cancerR P A'Hern, M E Gore
European Journal of Cancer (Oxford, England : 1990)|December 14, 2001
Caelyx: phase II studies in ovarian cancerS R Johnston, M E Gore
Clinical and Experimental Rheumatology|March 17, 2006
Scleroderma renal crisis sine scleroderma in pregnancy: a case reportJ E Gore, A N Brown
Lancet (London, England)|February 2, 1980
Chinese restaurant syndrome: fact or fiction?M E Gore, P R Salmon
Family Practice|September 1, 1991
Age of first confidential paediatric interview in primary careC Sylvester, L Kastner, E Gore
BJU International|February 19, 2008
Establishing the role of cytokine therapy in advanced renal cell carcinomaMartin E Gore, Pieter De Mulder
Nature|April 16, 1981
Prolactin inhibits oestrogen synthesis in the ovaryJ Dorrington, R E Gore-Langton
Pageof 32

Showing results (21-30 of 314) with videos related to

Sort By:
Pageof 32
Cancer Surveys|January 1, 1989
Lymphomas: the impact of chemotherapy on survivalM E Gore, T J McElwain
Anti-Cancer Drugs|October 1, 1995
The importance of dose and schedule in cancer chemotherapy: epithelial ovarian cancerP N Mainwaring, M E Gore
Drugs|July 24, 2001
Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapyD D Gibbs, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Impact of doxorubicin on survival in advanced ovarian cancerR P A'Hern, M E Gore
European Journal of Cancer (Oxford, England : 1990)|December 14, 2001
Caelyx: phase II studies in ovarian cancerS R Johnston, M E Gore
Clinical and Experimental Rheumatology|March 17, 2006
Scleroderma renal crisis sine scleroderma in pregnancy: a case reportJ E Gore, A N Brown
Lancet (London, England)|February 2, 1980
Chinese restaurant syndrome: fact or fiction?M E Gore, P R Salmon
Family Practice|September 1, 1991
Age of first confidential paediatric interview in primary careC Sylvester, L Kastner, E Gore
BJU International|February 19, 2008
Establishing the role of cytokine therapy in advanced renal cell carcinomaMartin E Gore, Pieter De Mulder
Nature|April 16, 1981
Prolactin inhibits oestrogen synthesis in the ovaryJ Dorrington, R E Gore-Langton
Pageof 32